H. Wilke

Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first-line treatment in patients with advanced oesophago-gastric cancer: a randomised, multicentre open-label phase II study.

R. Kurek, T. Ruhstaller, M. Valladares-Ayerbes, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors.

M. Yin, U. Vanhoefer, Y. Rustum, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer.

W. Hiddemann, B. Dörken, C. Köhne, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Esophageal Cancer: Neoadjuvant therapy for squamous cell esophageal carcinoma

J. Siewert, J. Roder, H. Stein, 1994 .

Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.

J. Siewert, U. Gunzer, H. Wilke, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.